Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$110M |
| 2 |
Willis Towers Watson
WTW
|
+$70.4M |
| 3 |
Gen Digital
GEN
|
+$63.3M |
| 4 |
Goldman Sachs
GS
|
+$53.6M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$51.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$110M |
| 2 |
Meta Platforms (Facebook)
META
|
+$72.2M |
| 3 |
Global Payments
GPN
|
+$43.3M |
| 4 |
Cardinal Health
CAH
|
+$41.2M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$40.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.08% |
| 2 | Technology | 14.83% |
| 3 | Healthcare | 8.61% |
| 4 | Consumer Discretionary | 7.67% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Brixmor Property Group
BRX
$8.99B
| $9.3M | 0.1% |
420,600
-11,800
| -3% | -$271K |
|
277
Aclaris Therapeutics
ACRS
$944M
| $9.23M | 0.1% |
512,875
+258,531
| +102% | +$4.14M |
|
|
MPT
278
Medical Properties Trust
MPT
$2.46B
| $9.23M | 0.1% |
+459,702
| New | +$9.42M |
|
279
AstraZeneca
AZN
$257B
| $9.22M | 0.1% |
+76,737
| New | +$8.93M |
|
280
Affiliated Managers Group
AMG
$9.21B
| $9.17M | 0.09% |
+60,721
| New | +$9.94M |
|
281
TransUnion
TRU
$16.2B
| $9.14M | 0.09% |
81,358
-129,205
| -61% | -$15.2M |
|
282
Brinker International
EAT
$10.6B
| $9.05M | 0.09% |
184,520
+161,720
| +709% | +$8.79M |
|
283
American Financial Group
AFG
$11.9B
| $9.02M | 0.09% |
71,693
-2,308
| -3% | -$301K |
|
284
Intercontinental Exchange
ICE
$90.5B
| $9.01M | 0.09% |
78,490
-169,710
| -68% | -$20.1M |
|
|
SRC
285
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $9.01M | 0.09% |
195,600
-88,416
| -31% | -$4.4M |
|
|
POW
286
DELISTED
Powered Brands Class A Ordinary Shares
POW
| $8.98M | 0.09% |
917,669
| – | – |
|
287
Teva Pharmaceuticals
TEVA
$43.5B
| $8.95M | 0.09% |
918,900
+301,800
| +49% | +$2.83M |
|
288
Globe Life
GL
$13.1B
| $8.94M | 0.09% |
100,435
-105,665
| -51% | -$9.87M |
|
289
Lyft
LYFT
$6.61B
| $8.92M | 0.09% |
166,381
-11,119
| -6% | -$590K |
|
290
Wendy's
WEN
$1.72B
| $8.84M | 0.09% |
407,900
+95,608
| +31% | +$2.18M |
|
291
Zillow
Z
$8.07B
| $8.84M | 0.09% |
+100,318
| New | +$10.1M |
|
|
CERN
292
DELISTED
Cerner Corp
CERN
| $8.8M | 0.09% |
124,772
+69,734
| +127% | +$5.39M |
|
|
ONC
293
PUT
BeOne Medicines Ltd
ONC
$42.4B
| $8.71M | 0.09% |
+24,000
| New | +$7.85M |
|
294
SBA Communications
SBAC
$19.4B
| $8.68M | 0.09% |
26,267
-24,740
| -49% | -$8.56M |
|
295
TransDigm Group
TDG
$66.4B
| $8.63M | 0.09% |
13,820
+3,133
| +29% | +$1.96M |
|
296
NVIDIA
NVDA
$5.2T
| $8.54M | 0.09% |
412,350
-804,130
| -66% | -$16.7M |
|
|
ROIC
297
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $8.53M | 0.09% |
489,567
-19,399
| -4% | -$341K |
|
298
Sphere Entertainment
SPHR
$5.69B
| $8.49M | 0.09% |
116,889
+8,656
| +8% | +$649K |
|
|
VZIO
299
DELISTED
VIZIO Holding Corp.
VZIO
| $8.45M | 0.09% |
397,682
+177,920
| +81% | +$3.89M |
|
300
Constellium
CSTM
$3.66B
| $8.43M | 0.09% |
448,700
+434,100
| +2,973% | +$8.36M |
|
Similar funds
Steve Schonfeld's Q3 2021 Portfolio in Review
As of Q3 2021, Steve Schonfeld held 2,698 positions worth $9.68B, up 3% from $9.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Steve Schonfeld deployed $368M of net new capital in Q3 2021, opening 807 new positions and adding to 606 existing holdings. Its largest new stake was Arthur J. Gallagher & Co: 770,871 shares worth $115M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Amazon, an estimated $110M trimmed.
- Steve Schonfeld's largest Q3 2021 buy was Arthur J. Gallagher & Co: 770,871 shares worth $115M.
- Steve Schonfeld added most to Willis Towers Watson in Q3 2021, an estimated $70.4M increase.
- Steve Schonfeld's biggest Q3 2021 reduction was Amazon, cutting an estimated $110M.
- Steve Schonfeld fully exited Cardinal Health in Q3 2021, selling an estimated $41.2M.
- Steve Schonfeld's ten largest holdings make up 11% of its $9.68B portfolio in Q3 2021.
- Steve Schonfeld opened 807 new positions and closed 588 in Q3 2021.
- Steve Schonfeld's portfolio value rose 3% quarter-over-quarter to $9.68B.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.